Net delta exposure for Pacific Biosciences of California Inc (PACB) options was $33.07M per 1% move at the Nov 4, 2026 close. It has been positive on 20 of the last 20 trading days. Four weeks earlier, on Oct 7, 2026, it was $30.51M.
Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.
Delta Exposure by Strike
Showing results for PACB, 2026-11-20(m), calls & puts
Delta Exposure Stats
Showing results for PACB, 2026-11-20(m), calls & puts
Net Delta Exposure by Expiration
Showing results for PACB, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net DEX | Call DEX | Put DEX | Call Wall | Put Wall |
|---|
PACB Delta Exposure FAQ
What is delta exposure (DEX)?
Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.
Is PACB delta exposure positive or negative?
Pacific Biosciences of California net delta exposure was positive on Nov 4, 2026, at $33.07M. It has been positive on 20 of the last 20 trading days.
How has PACB delta exposure changed recently?
Pacific Biosciences of California net delta exposure went from $30.51M on Oct 7, 2026 to $33.07M on Nov 4, 2026. See the PACB delta exposure history for a longer view.
What is Pacific Biosciences of California Inc?
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems.